ClinicalTrials.Veeva

Menu
N

Newcastle upon Tyne Hospitals NHS Foundation Trust | John Walton Muscular Dystrophy Research Centre

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

DYNE-101

Parent organization

This site is a part of Newcastle upon Tyne Hospitals NHS Foundation Trust

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 8 total trials

Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1 (ACHIEVE)

The primary purpose of the study is to evaluate the safety and tolerability of multiple intravenous (IV) doses of DYNE-101 administered to participan...

Enrolling
Myotonic Dystrophy Type 1 (DM1)
Drug: Placebo
Drug: DYNE-101

Trial sponsors

N
Virginia Commonwealth University (VCU) logo
D
I

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems